• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 31st January 2015

Universal Health Coverage: The Holy Grail? 21st Annual Lecture Publication.

The 21st OHE Annual Lecture was given by Professor Anne Mills, London School of Hygiene and Tropical Medicine, on the subject of Universal Health Coverage in low- and middle-income countries. The 21st OHE Annual Lecture was given by Professor Anne…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The 21st OHE Annual Lecture was given by Professor Anne Mills, London School of Hygiene and Tropical Medicine, on the subject of Universal Health Coverage in low- and middle-income countries.

The 21st OHE Annual Lecture was given by Professor Anne Mills, London School of Hygiene and Tropical Medicine, on the subject of Universal Health Coverage in low- and middle-income countries. It is now available as a publication and can be downloaded here.
 
Health services available to the entire population free of charge, and providing the best health advice and treatment, was the foundation stone for the creation of the National Health Service. The health systems of most other high income countries similarly embody the ideal of universal health coverage.
 
Yet low- and lower-middle-income countries have recently been on the receiving end of global policies that have emphasised highly selective goals, in contrast to the initial broad themes pursued through the WHO’s slogan Health for All. Recent policies have focussed on controlling specific diseases such as HIV and malaria and delivering specific interventions such as immunisation.
 
There is general agreement that this disease-specific focus has led to adverse consequences, in particular the neglect of the health system infrastructure improvements needed to underpin the delivery of interventions. This has led to high competition for scarce health workers and managers, lack of general training for these workers, and a lack of support for cross-cutting systems issues such as primary care and district infrastructure that all programmes depend on.
 
In addition, in many countries, a high proportion of health care spending comes from out-of-pocket payments, which leads to the risk of “catastrophic” health care expenditure and thus household poverty. 
 
In recent years, however, universal health coverage has attracted greater attention. It has been the subject of World Health Assembly and UN General Assembly resolutions, and is being strongly advocated for inclusion in the post-2015 Millennium Development Goals.
 
In this publication, Professor Mills discusses universal health coverage in the context of low- and middle-income countries and what can be learned from the experiences of countries already tackling the key challenges in making progress towards it. The discussion is framed around each of the key stakeholders in a health system, including the population/patients, providers of services, financial intermediaries and the government/professional bodies.
 
Professor Mills concludes that universal coverage can eventually be achieved if the necessary elements are put in place, where these include:
• The appropriate combination of financing sources, including a core mandatory mechanism;
• Means to extend financial protection, notably to the informal sector and the non-working population;
• A strong purchasing role encompassing both public and private providers, with emphasis on health promotion and prevention;
• Payment systems with appropriate incentives for cost containment and quality of care;
• Strong primary-care and local-level infrastructure with geographical access reaching poorer areas.
 

Universal Health Coverage: The Holy Grail? from Office of Health Economics

 

  • Health Care Systems
  • Annual Lecture

Related News

  • News
  • June 2020

The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?

Read more
  • News
  • August 2019

OHE Annual Lecture 2019: The Evolution of U.S. Policy Responses to the Opioid Epidemic

Read more
  • News
  • July 2018

Invitation to OHE’s Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?

Read more
  • News
  • March 2018

Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe? 24th Annual Lecture Publication

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!